JNK Suppresses Apoptosis via Phosphorylation of the Proapoptotic Bcl-2 Family Protein BAD

Molecular Cell

Volumn 13, Issue 3, 2004, Pages 329-340

  Yu, Chenfei ^a   Minemoto, Yuzuru ^a   Zhang, Jiyan ^a   Liu, Jing ^a   Tang, Fangming ^a   Bui, Truc N ^a   Xiang, Jialing ^a,b   Lin, Anning ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b Illinois Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CARRIER PROTEIN; INTERLEUKIN 3; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAD; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN BCL XL; STRESS ACTIVATED PROTEIN KINASE; THREONINE;

ANIMAL; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL LINE; CELL SURVIVAL; CELL TYPE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; ENZYME ACTIVITY; GENETICS; METABOLISM; MOLECULAR DYNAMICS; MOUSE; MUTATION; NONHUMAN; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; STIMULUS RESPONSE;

ANIMALIA;

EID: 1242316958     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(04)00028-0     Document Type: Article

References (50)

1. Bost F., McKay R., Bost M., Potapova O., Dean N.M., Mercola D. The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells. Mol. Cell. Biol. 19:1999;1938-1949.
2. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature. 410:2001;37-40.
3. Chen N., Nomura M., She Q.B., Ma W.Y., Bode A.M., Wang L., Flavell R.A., Dong Z. Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice. Cancer Res. 61:2001;3908-3912.
4. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91:1997;231-241.
5. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell. 103:2000;239-252.
6. del Peso L., Gonzalez-Garcia M., Page C., Herrera R., Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science. 278:1997;687-689.
7. Deng Y., Ren X., Yang L., Lin Y., Wu X. A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell. 115:2003;61-70.
8. Derijard B., Raingeaud J., Barrett T., Wu I.H., Han J., Ulevitch R.J., Davis R.J. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science. 267:1995;682-685.
9. De Smaele E., Zazzeroni F., Papa S., Nguyen D.U., Jin R., Jones J., Cong R., Franzoso G. Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature. 414:2001;308-313.
10. Donovan N., Becker E.B., Konishi Y., Bonni A. JNK phosphorylation and activation of BAD couples the stress-activated signaling pathway to the cell death machinery. J. Biol. Chem. 277:2002;40944-40949.
11. Harada H., Becknell B., Wilm M., Mann M., Huang L.J., Taylor S.S., Scott J.D., Korsmeyer S.J. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol. Cell. 3:1999;413-422.
12. Hess P., Pihan G., Sawyers C.L., Flavell R.A., Davis R.J. Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts. Nat. Genet. 32:2002;201-205.
13. Hibi M., Lin A., Smeal T., Minden A., Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7:1993;2135-2148.
14. Hinton H.J., Welham M.J. Cytokine-induced protein kinase B activation and BAD phosphorylation do not correlate with cell survival of hemopoietic cells. J. Immunol. 162:1999;7002-7009.
15. Ichijo H., Nishida E., Irie K., ten Dijke P., Saitoh M., Moriguchi T., Takagi M., Matsumoto K., Miyazono K., Gotoh Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science. 275:1997;90-94.
16. Ito M., Yoshioka K., Akechi M., Yamashita S., Takamatsu N., Sugiyama K., Hibi M., Nakabeppu Y., Shiba T., Yamamoto K.I. JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway. Mol. Cell. Biol. 19:1999;7539-7548.
17. Jacobson M.D., Weil M., Raff M.C. Programmed cell death in animal development. Cell. 88:1997;347-354.
18. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:1995;16483-16486.
19. Karin M., Lin A. NF-kappaB at the crossroads of life and death. Nat. Immunol. 3:2002;221-227.
20. L. Mol. Cell. Biol. 17:1997;7040-7046.
21. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis. a basic biological phenomenon with wide-ranging implications in tissue kinetics Br. J. Cancer. 26:1972;239-257.
22. Kuan C.Y., Yang D.D., Samanta Roy D.R., Davis R.J., Rakic P., Flavell R.A. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron. 22:1999;667-676.
23. Lin A. Activation of the JNK signaling pathway. breaking the brake on apoptosis Bioessays. 25:2003;1-8.
24. Lin A., Frost J.A., Deng T., Smeal T., Al-Alawi N., Kikkawa U., Hunter T., Brenner D.A., Karin M. Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity. Cell. 70:1992;777-789.
25. Lin A., Minden A., Martinetto H., Claret F.X., Lange-Carter C., Mercurio F., Johnson G.L., Karin M. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science. 268:1995;286-290.
26. Lu X., Nemoto S., Lin A. Identification of c-Jun NH2-terminal protein kinase (JNK)-activating kinase 2 as an activator of JNK but not p38. J. Biol. Chem. 272:1997;24751-24754.
27. Maeda S., Chang L., Li Z.-W., Luo J.-L., Leffert H., Karin M. IKKβ is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFα Immunity. 19:2003;725-737.
28. McDonald P.H., Chow C.W., Miller W.E., Laporte S.A., Field M.E., Lin F.T., Davis R.J., Lefkowitz R.J. Beta-arrestin 2. a receptor-regulated MAPK scaffold for the activation of JNK3 Science. 290:2000;1574-1577.
29. Minden A., Lin A., McMahon M., Lange-Carter C., Derifard B., Davis R., Johnson G., Karin M. Bifurcation in Ras signaling. Raf-1 and MEKK-1 differentially activate ERK and JNK MAP kinases Science. 256:1994;1719-1723.
30. Potapova O., Anisimov S.V., Gorospe M., Dougherty R.H., Gaarde W.A., Boheler K.R., Holbrook N.J. Targets of c-Jun NH(2)-terminal kinase 2-mediated tumor growth regulation revealed by serial analysis of gene expression. Cancer Res. 62:2002;3257-3263.
31. Rinkenberger J.L., Korsmeyer S.J. Errors of homeostasis and deregulated apoptosis. Curr. Opin. Genet. Dev. 7:1997;589-596.
32. Sabapathy K., Jochum W., Hochedlinger K., Chang L., Karin M., Wagner E.F. Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech. Dev. 89:1999;115-124.
33. Salmeron A., Ahmad T.B., Carlile G.W., Pappin D., Narsimhan R.P., Ley S.C. Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. EMBO J. 15:1996;817-826.
34. Sanchez I., Hughes R.T., Mayer B.J., Yee K., Woodgett J.R., Avruch J., Kyriakis J.M., Zon L.I. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature. 372:1994;794-798.
35. Scheid M.P., Schubert K.M., Duronio V. Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase. J. Biol. Chem. 274:1999;31108-31113.
36. Shibuya H., Yamaguchi K., Shirakabe K., Tonegawa A., Gotoh Y., Ueno N., Irie K., Nishida E., Matsumoto K. TAB1. an activator of the TAK1 mapkkk in tgf-beta signal transduction Science. 272:1996;1179-1182.
37. Tang G., Minemoto Y., Dibling B., Purcell N.H., Li Z., Karin M., Lin A. Inhibition of JNK activation through NF-kappaB target genes. Nature. 414:2001;313-317. a.
38. Tang G., Yang J., Minemoto Y., Lin A. Blocking caspase-3-mediated proteolysis of IKKbeta suppresses TNF-alpha-induced apoptosis. Mol. Cell. 8:2001;1005-1016. b.
39. Tang F., Tang G., Xiang J., Dai Q., Rosner M.R., Lin A. Absence of NF-kB-mediated inhibition of c-Jun N-terminal kinase activation contributes to tumor necrosis factor alpha-induced apoptosis. Mol. Cell. Biol. 22:2002;8571-8579.
40. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
41. Tibbles L.A., Ing Y.L., Kiefer F., Chan J., Iscove N., Woodgett J.R., Lassam N.J. MLK-3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6. EMBO J. 15:1996;7026-7035.
42. Tournier C., Whitmarsh A.J., Cavanagh J., Barrett T., Davis R.J. Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase. Proc. Natl. Acad. Sci. USA. 94:1997;7337-7342.
43. Wang H.G., Rapp U.R., Reed J.C. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell. 87:1996;629-638.
44. Wang H.G., Pathan N., Ethell I.M., Krajewski S., Yamaguchi Y., Shibasaki F., McKeon F., Bobo T., Franke T.F., Reed J.C. Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science. 284:1999;339-343.
45. Whitmarsh A.J., Cavanagh J., Tournier C., Yasuda J., Davis R.J. A mammalian scaffold complex that selectively mediates MAP kinase activation. Science. 281:1998;1671-1674.
46. Xia Y., Makris C., Su B., Li E., Yang J., Nemerow G.R., Karin M. MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration. Proc. Natl. Acad. Sci. USA. 97:2000;5243-5248.
47. Yaffe M.B. How do 14-3-3 proteins work? - Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Lett. 513:2002;53-57.
48. Yujiri T., Sather S., Fanger G.R., Johnson G.L. Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption. Science. 282:1998;1911-1914.
49. Zha J., Harada H., Yang E., Jockel J., Korsmeyer S.J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell. 87:1996;619-628.
50. Zheng C., Xiang J., Hunter T., Lin A. The JNKK2-JNK1 fusion protein acts as a constitutively active c-Jun kinase that stimulates c-Jun transcription activity. J. Biol. Chem. 274:1999;28966-28971.